IRS (finally) issues guidance for the cannabis industry
In September 2020, the Internal Revenue Service (IRS) published an entire webpage on their site dedicated to tax policy for the cannabis industry – particularly marijuana businesses. The site includes information on a number of relevant topics such as Internal Revenue Code (IRC) section 280E guidance, reporting taxes, making large payments with cash and more.
Although marijuana remains a banned substance under U.S. federal law, thus depriving those in the industry of certain federal benefits otherwise enjoyed by legal businesses (i.e., tax deductions for business expenses other than cost of goods sold (COGS) or bankruptcy, copyright and trademark protections), cannabis companies still have an obligation to pay taxes and properly report transactions. The latest guidance provided by the IRS is designed to “help promote voluntary compliance in the industry.”
So what does the IRS have to say about marijuana companies and taxes?
Overview: What is in the tax guidance?
The new IRS webpage addressing tax concerns for cannabis companies aims to inform business owners about their tax compliance responsibilities.
The page notes that although many cannabis industry businesses conduct operations with cash, these transactions must be reported like any other form of payment. It also provides information about income reporting, cash payment options for unbanked taxpayers, estimated US federal income tax payments, and the importance of robust recordkeeping (i.e., cash sourcing and tracking).
In addition, the webpage includes several resources pertaining to concerns of the cannabis industry. Among these resources are: Frequently Asked Questions (FAQ), information about paying your taxes in cash, and reporting single cash transactions of more than $10,000. In addition, it provides a cash-intensive business audit techniques guide.
Is income from the sale of marijuana federally taxable?
While still prohibited under federal law, today, more than half of U.S. states and the District of Columbia have laws legalizing marijuana for either medical or recreational use. At the start of 2021, the breakdown is as follows:
Legalized Marijuana for Medical Use: Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Hawaii, Illinois, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, Utah, Vermont, Virginia, Washington and West Virginia.
Legalized Marijuana for Recreational Use: Alaska, Arizona, California, Colorado, District of Columbia, Illinois, Maine, Massachusetts, Michigan, Montana, New Jersey, Nevada, Oregon, South Dakota, Vermont and Washington.
However, regardless of the legality of the product or business operation, for US income tax purposes, income from any source is taxable, including income from the sale of marijuana or marijuana-related products. The IRS indicates on their new webpage that federal courts have consistently upheld the IRS’ determination that income derived from both state compliant, as well non-compliant, or illegal marijuana sales are subject to US federal income tax.
What does the IRS say about IRC section 280E?
The IRS reminds “businesses that traffic marijuana in contravention of federal or state law” that they are subject to the limitations of Internal Revenue Code (IRC) section 280E. As many in the industry know, section 280E disallows US federal income tax deductions for business operating expenses other than cost of goods sold, which results in extraordinarily high US federal effective income tax rates and cash tax liabilities that are not in line with the actual economic costs of operations, which has severely negatively impacted marijuana-related businesses.
What is included in the IRS’ marijuana industry Frequently Asked Questions (FAQ)?
As mentioned above, one resource the IRS issued in conjunction with their new webpage is a Marijuana Industry FAQ. On a broad scale, the FAQ addresses federal tax filing and information reporting requirements specific to taxpayers involved with the production, processing, sale or distribution of marijuana products.
The page explains how court rulings have clarified that businesses must pay US federal income taxes, even if they are selling products considered illegal under state or federal law. It also explains that marijuana companies are eligible for payment plans if they are unable to pay their taxes in full. Further, it states that cannabis operations are subject to the same penalties as any other business during an income tax examination by the IRS.
The FAQ also note that while section 280E disallows all deductions or credits for any amount paid or incurred in carrying on any business that violates federal drug laws (including those that sell marijuana in states that have legalized the sale of marijuana), section 280E does not prohibit a participant in the marijuana industry from reducing their gross receipts by properly calculating their cost of goods sold (COGS) to determine gross income. Generally, this means that taxpayers that legally sell marijuana may reduce their gross receipts by the cost of acquiring or producing marijuana that they sell, but these costs will depend on the nature of the business. In other words, while cannabis businesses are not eligible for most traditional deductions, they are able to calculate the cost of goods sold and attain some tax relief. So, for example, “no” to deducting advertising costs, but “yes” to deducting COGS.
What is the general takeaway of the IRS adding these webpages?
Pending a change in the federal status of marijuana (e.g., descheduling as a Schedule 1 substance under the CSA), or statutory changes at the agency level, the cannabis industry will continue to be at a disadvantage when it comes to general business and tax allowances – like deducting expenses or even having access to a bank or credit union to conduct routine financial transactions.
However, the inclusion of tax policy guidance by the IRS, a US federal agency, for marijuana businesses is a positive step toward acknowledging the cannabis industry as one significant enough to warrant establishment of a formal policy on tax collection and reporting, as well as provide some general guidance and answers to taxpayers’ questions which up until now had gone unanswered. The issuance of a dedicated webpage on IRS.gov is a significant signal of not only increased scrutiny but perhaps also of potential developments to reduce taxpayer uncertainty aimed at increased tax compliance.
How can Baker Tilly help?
Baker Tilly takes pride in being a business leader working with those in the cannabis industry to handle all of their accounting, tax and business consulting needs. Our Cannabis industry Value Architects™ have unrivaled experience and dedication to working with cannabis clients and understand the uniqueness of the industry and the depths of the concerns without federal protections. Please reach out to ask questions and develop insightful strategies for the short-term and long-term needs of your business.
